Department of Public Health Sciences, School of Public Health, University of Alberta, Edmonton, Canada
Department of Psychiatry, University of Cambridge, Cambridge, UK
Medical Research Council National Survey of Health and Development, Department of Epidemiology and Public Health, University College London Medical School, London, UK
Department of Psychiatry, University of Cambridge, Cambridge, UK
Correspondence: Ian Colman, Department of Public Health Sciences, School of Public Health, University of Alberta, 13-130D Clinical Sciences Building, Edmonton, Alberta T6G 2G3, Canada. Email: ian.colman{at}ualberta.ca
None. Funding detailed in the Acknowledgements.
Background
Antidepressants and anxiolytics have demonstrated short-term efficacy; however, little is known about the long-term effectiveness of these drugs.
Aims
To investigate long-term psychiatric outcomes following antidepressant and/or anxiolytic use during an episode of mental disorder in mid-life.
Method
Members of the 1946 British birth cohort were assessed for symptoms of depression and anxiety at age 43. Among 157 with mental disorder, those using antidepressants and/or anxiolytics were compared with those not using medications on psychiatric outcomes at age 53.
Results
Use of antidepressants or anxiolytics was associated with a lower prevalence of mental disorder at age 53 (odds ratio (OR)=0.3, 95% CI 0.1–1.0) after adjustment for eight variables in a propensity-for-treatment analysis. Only 24% of those being treated with medications at age 43 were still using them at 53.
Conclusions
Use of antidepressants or anxiolytics during an episode of mental disorder may have long-term beneficial effects on mental health. This may be because of a demonstrated willingness to seek help rather than long-term maintenance therapy.
Related articles in BJP: